<?xml version="1.0" encoding="UTF-8"?>
<p id="Par37">Aspirin will be purchased from Bayer Pharma, Ltd. Metformin will be purchased from Dainippon Sumitomo Pharma Co., Ltd. The placebo (250â€‰mg lactose) will be purchased from Kondo photo process Co., Ltd., Osaka, Japan. All trial drugs will be packaged identically and identified only by number. Subjects will be instructed to take two tablets of the trial drugs after breakfast each day. Compliance will be monitored by counting the empty drug packages returned by the patients at colonoscopy. The participants will be also interviewed and monitored that they had not used prohibited agents (aspirin, metformin and/or other non-steroidal anti-inflammatory drugs). If serious adverse events or less than 80% drug compliance are confirmed in a patient, that patient will be removed from the final analysis.</p>
